ShaTin, Hong Kong – Aasraw Biochemical Technology Co. is proud to announce it is rapidly becoming one of the world’s most rapidly growing pharmaceutical leaders.
Based in Hong Kong, Aasraw has been in operation since 2008. The company is the legal manufacturer of Isotretinoin API, a highly effective medication used in the treatment of severe acne and prevention of certain skin cancers.
“Our company was originally the Biochemical Engineering Laboratory, based in Shanghai,” says King Zhang, one of Aasraw’s founding members. “It was built by 5 Chinese PhD doctors who all majored in Chemical Engineering at the University of Tulsa, Oklahoma.”
According to their website, Aasraw has quickly garnered attention as one of the world’s leading companies in the biochemical industry. As a result of their success, the company has attracted a large amount of highly qualified professionals in the field and uses state-of-the-art equipment and instruments to analyze, test, and synthesize their products.
“With fixed assets of more than $30 million USD, we anticipate continued growth well into the future,” Zhang states. “We have many scheduled projects in the coming years with adopted and patented technology.”
Aasraw prides itself in manufacturing only the highest quality products under strict regulations. It vigorously adheres to cGMP regulations under a tractable quality system. The company also guarantees its products for top quality and stable bulk supply.
“We look forward to the growth of our company,” says Zhang. “With innovative ideas and the best chemical engineers, we can only go up from here.”
In addition to manufacturing Isotretinoin API, Aasraw also produces high quality Anabolics Steroids, Female Hormones, Sex Enhancing Hormones, Prohormones, Fat Loss Powder, Nootropics Powder, PCT Drugs, SARMS, Plant Extract, and R&D Reagents.
For more information about Aasraw, or to view their frequently asked questions, please visit the company’s website at https://www.aasraw.com/.